Figure 1.
Kaplan-Meier PFS and OS estimates. The survival analysis included 37 patients with evaluable disease. Median PFS was 10.2 months (95% CI 5.5-13.7 mo) (A); median OS was 14.3 months (95% CI 10.2-35.6) (B).
Kaplan-Meier PFS and OS estimates. The survival analysis included 37 patients with evaluable disease. Median PFS was 10.2 months (95% CI 5.5-13.7 mo) (A); median OS was 14.3 months (95% CI 10.2-35.6) (B).